Atlas Trials

Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia

Clinical trial NCT02363075 · UNKNOWN

Trial details

NCT number
NCT02363075
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Glioma
Start date
2013-04-01
Primary completion
2017-07-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.